Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of tumors: A preclinical study of cervical carcinoma and melanoma xenografts

References

• Jennings D, Raghunand N, Gillies RJ. Imaging hemodynamics. Cancer Metastasis Rev 2008;27:589–613.
   PubMed Web of Science ®Google Scholar
• Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, . Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusable tracer: Standardized quantities and symbols. J Magn Reson Imaging 1999;10:223–32.
   PubMed Web of Science ®Google Scholar
• Zahra MA, Hollingsworth KG, Sala E, Lomas DJ, Tan LT. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol 2007;8:63–74.
   PubMed Web of Science ®Google Scholar
• Hylton N. Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker. J Clin Oncol 2006;24: 3293–8.
   PubMed Web of Science ®Google Scholar
• Benjaminsen IC, Graff BA, Brurberg KG, Rofstad EK. Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: A preclinical study of human melanoma xenografts. Magn Reson Med 2004;52: 269–76.
   PubMed Web of Science ®Google Scholar
• Egeland TAM, Simonsen TG, Gaustad JV, Gulliksrud K, Ellingsen C, Rofstad EK. Dynamic contrast-enhanced magnetic resonance imaging of tumors: Preclinical validation of parametric images. Radiat Res 2009;172:339–47.
   PubMed Web of Science ®Google Scholar
• Egeland TAM, Gaustad JV, Vestvik IK, Benjaminsen IC, Mathiesen B, Rofstad EK. Assessment of fraction of radiobiologically hypoxic cells in human melanoma xenografts by dynamic contrast-enhanced MRI. Magn Reson Med 2006;55:874–82.
   PubMed Web of Science ®Google Scholar
• Gulliksrud K, Øvrebø KM, Mathiesen B, Rofstad EK. Differentiation between hypoxic and non-hypoxic experimental tumors by dynamic contrast-enhanced magnetic resonance imaging. Radiother Oncol 2011;98:360–4.
   PubMed Web of Science ®Google Scholar
• Egeland TAM, Gulliksrud K, Gaustad JV, Mathiesen B, Rofstad EK. Dynamic contrast-enhanced MRI of tumor hypoxia. Magn Reson Med 2012;67:519–30.
   PubMed Web of Science ®Google Scholar
• Vaupel P, Mayer A. Hypoxia in cancer: Significance and impact on clinical outcome. Cancer Metastasis Rev 2007; 26:225–39.
   PubMed Web of Science ®Google Scholar
• Ellingsen C, Natvig I, Gaustad JV, Gulliksrud K, Egeland TAM, Rofstad EK. Human cervical carcinoma xenograft models for studies of the physiological microenvironment of tumors. J Cancer Res Clin Oncol 2009;135:1177–84.
   PubMed Web of Science ®Google Scholar
• Rofstad EK, Mathiesen B. Metastasis in melanoma xenografts is associated with tumor microvascular density rather than extent of hypoxia. Neoplasia 2010;12:889–98.
   PubMed Web of Science ®Google Scholar
• Hittmair K, Gomiscek G, Langenberger K, Recht M, Imhof H, Kramer J. Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med 1994;31:567–71.
   PubMed Web of Science ®Google Scholar
• Ellingsen C, Egeland TAM, Galappathi K, Rofstad EK. Dynamic contrast-enhanced magnetic resonance imaging of human cervical carcinoma xenografts: Pharmacokinetic analysis and correlation to tumor histomorphology. Radiother Oncol 2010;97:217–24.
   PubMed Web of Science ®Google Scholar
• Killion JJ, Radinsky R, Fidler IJ. Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev 1999;17:279–84.
   Web of Science ®Google Scholar
• Talmadge JE, Singh RK, Fidler IJ, Raz A. Murine models to evaluate novel and conventional therapeutic strategies for cancer. Am J Pathol 2007;170:793–804.
   PubMed Web of Science ®Google Scholar
• Gaustad JV, Benjaminsen IC, Graff BA, Brurberg KG, Ruud EBM, Rofstad EK. Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 2005;21:792–800.
   PubMed Web of Science ®Google Scholar
• Egeland TAM, Gaustad JV, Galappathi K, Rofstad EK. Magnetic resonance imaging of tumor necrosis. Acta Oncol 2011;50:427–34.
   PubMed Web of Science ®Google Scholar
• Øvrebø KM, Hompland T, Mathiesen B, Rofstad EK. Assessment of hypoxia and radiation response in intramuscular experimental tumors by dynamic contrast-enhanced magnetic resonance imaging. Radiother Oncol 2012;102: 429–35.
   PubMed Web of Science ®Google Scholar
• Ellingsen C, Egeland TAM, Gulliksrud K, Gaustad JV, Mathiesen B, Rofstad EK. Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2009;73:838–45.
   PubMed Web of Science ®Google Scholar
• Sundfør K, Lyng H, Rofstad EK. Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix. Br J Cancer 1998; 78:822–7.
   PubMed Web of Science ®Google Scholar
• Pitson G, Fyles A, Milosevic M, Wylie J, Pintilie M, Hill RP. Tumor size and oxygenation are independent predictors of nodal disease in patients with cervix cancer. Int J Radiat Oncol Biol Phys 2001;51:699–703.
   PubMed Web of Science ®Google Scholar
• Cairns RA, Hill RP. Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma. Cancer Res 2004;64: 2054–61.
   PubMed Web of Science ®Google Scholar
• Rofstad EK, Rasmussen H, Galappathi K, Mathiesen B, Nilsen K, Graff BA. Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor. Cancer Res 2002;62:1847–53.
   PubMed Web of Science ®Google Scholar
• Ellingsen C, Hompland T, Mathiesen B, Rofstad EK. Microenvironment-associated lymph node metastasis of human cervical carcinoma xenografts. Acta Oncol 2012;51: 465–72.
   PubMed Web of Science ®Google Scholar
• Schoppmann SF, Fenzl A, Schindl M, Bachleitner- Hofmann T, Nagy K, Gnant M, . Hypoxia inducible factor-1α correlates with VEGF-C expression and lymphangiogenesis in breast cancer. Breast Cancer Res Treat 2006; 99:135–41.
   PubMed Web of Science ®Google Scholar
• Min Y, Ghose S, Boelte K, Li J, Yang L, Lin PC. C/EBP-δ regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1α. Oncogene 2011;30:4901–9.
   PubMed Web of Science ®Google Scholar
• Chaudary N, Milosevic M, Hill RP. Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer. Gynecol Oncol 2011;123:393–400.
   PubMed Web of Science ®Google Scholar
• Li LZ, Zhou R, Xu HN, Moon L, Zhong T, Kim EJ, . Quantitative magnetic resonance and optical imaging biomarkers of melanoma metastatic potential. Proc Natl Acad Sci USA 2009;106:6608–13.
   PubMed Web of Science ®Google Scholar
• Tatum JL, Kelloff GJ, Gillies RJ, Arbeit JM, Brown JM, Chao KS, . Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol 2006;82:699–757.
   PubMed Web of Science ®Google Scholar
• Pacheco-Torres J, López-Larrubia P, Ballesteros P, Cerdán S. Imaging tumor hypoxia by magnetic resonance methods. NMR Biomed 2011;24:1–16.
   PubMed Web of Science ®Google Scholar
• Øvrebø KM, Gulliksrud K, Mathiesen B, Rofstad EK. Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2011;81:255–61.
   PubMed Web of Science ®Google Scholar
• Øvrebø KM, Ellingsen C, Galappathi K, Rofstad EK. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts. Int J Radiat Oncol Biol Phys 2012;83:e121–7.
   Google Scholar